What Is a Hemophilia Treatment Center (HTC) and Why?
At a Glance
A Hemophilia Treatment Center (HTC) is a specialized clinic where a coordinated team helps manage hemophilia and other inherited bleeding disorders. It can complement local hematology care through comprehensive evaluations, preventive treatment planning, joint monitoring, and emergency support.
In this answer
4 sections
The Bottom Line: A Hemophilia Treatment Center (HTC) is a specialized clinic providing comprehensive care for hemophilia and other inherited bleeding disorders. It does not necessarily have to replace your local hematologist; instead, it can complement your regular care, offering a shared-care approach that adds specialized expertise when you need it.
A Hemophilia Treatment Center (HTC) acts as a “medical home” for people with inherited bleeding disorders. While a local hematologist is qualified to treat blood conditions, an HTC focuses specifically on the complex needs of bleeding disorders using a coordinated team approach [1][2]. For many patients, managing hemophilia A involves more than just clotting factor prescriptions. It requires an individualized plan that may include joint-and-muscle assessment, emotional support, and navigating insurance [1][3].
The Multidisciplinary Care Team
The cornerstone of an HTC is its team-based care model. While services vary by center, and not all specialists may be present at every appointment, a comprehensive HTC team may include:
- Hematologists: Doctors who specialize in blood disorders, oversee your overall hemophilia treatment plan, and help coordinate surgical or dental care [1][4].
- Nurse Coordinators: Specialized nurses who provide ongoing education, assist with home-treatment training, and act as a bridge between you and the rest of the team [1][5].
- Physical Therapists: Specialists who assess joint health, treat muscle pain, and recommend non-drug therapies (like splints or aquatic therapy) to protect your joints [6][7].
- Social Workers and Psychologists: Professionals who offer emotional support, helping patients navigate the stress of a chronic illness and find community resources [8][9].
- Clinical Pharmacists: Experts who monitor how your body handles medicines, assist with proper dosing, and help ensure you can take your treatment as planned [2].
What Can an HTC Add to My Care?
Treating hemophilia A is highly individualized based on your factor VIII levels, age, and bleeding pattern. Care often involves prophylaxis (preventive treatments like factor replacement or non-factor therapies such as emicizumab) and monitoring for inhibitors (antibodies that can stop specific infused clotting factors from working) [3][10].
Research suggests that the specialized coordination at HTCs is associated with improved health outcomes [1]. For example:
- Fewer Emergencies: In one rural U.S. quality-improvement project, coordinated HTC interventions were associated with an 85.4% reduction in preventable bleeding-related emergency room visits and hospitalizations [11].
- Support for Preventive Care: Patients treated at specialized centers are more likely to be on prophylactic treatments, which can reduce bleeding episodes and help preserve joint motion, though bleeds can still happen [12][13].
- Specialized Monitoring: Studies comparing expert hemophilia facilities to non-expert facilities note that patients at expert centers receive more consistent joint examinations and specific laboratory testing for factor VIII levels or inhibitors when clinically indicated [14].
- Patient Satisfaction: In national U.S. surveys, over 94% of patients rated their overall care at an HTC as “always” or “usually” satisfactory [15].
What to Expect at a Comprehensive HTC Visit
A comprehensive annual evaluation at an HTC usually includes:
- A review of your bleeding history and current treatment plan.
- A joint and musculoskeletal assessment.
- Laboratory testing for factor levels or inhibitors (only if clinically indicated).
- Planning for any upcoming surgeries, dental work, or physical activities.
- Assistance with insurance or emotional concerns.
Shared Care: What If You Live Far From an HTC?
If you live far from an HTC, you can often arrange a “shared-care” approach. This allows you to see your local doctor for routine visits while completing a comprehensive annual evaluation at the HTC [16].
Many HTCs also provide telehealth check-ins and written emergency treatment plans for your local emergency department [5][17]. After-hours arrangements vary, so it is important to confirm how your specific center handles emergencies.
Safety Note: Never delay local emergency care or attempt to travel far to an HTC if you suspect a serious head, neck, eye, or abdominal bleed, or if you have uncontrolled bleeding. Follow your individualized written emergency plan and ask local staff to contact your HTC or hematologist.
Common questions in this guide
What does a Hemophilia Treatment Center do?
Do I have to stop seeing my local hematologist if I use an HTC?
What happens during a comprehensive HTC visit?
How can an HTC help with hemophilia A treatment?
What if I live far from a Hemophilia Treatment Center?
When should I seek emergency care instead of traveling to an HTC?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Shared care
Could a hemophilia treatment center work alongside my local hematologist?
Care team roles
What kinds of team members would be part of a hemophilia treatment center's care?
Support services
Can a hemophilia treatment center help with joint checks, emotional support, or insurance questions?
Related questions
Show more
Get notified when new evidence is published on Hemophilia A.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders.
Valentino LA, Baker JR, Butler R, et al.
Journal of blood medicine 2021; (12()):897-911 doi:10.2147/JBM.S325031.
PMID: 34707421 - 2
Expanding Pharmacy Services to the Hemophilia Treatment Center.
Charafi L, Campanella L, Shay B, et al.
Hospital pharmacy 2023; (58(5)):415-419 doi:10.1177/00185787231163262.
PMID: 37711404 - 3
Current challenges in the management of hemophilia.
Bauer KA
The American journal of managed care 2015; (21(6 Suppl)):S112-22.
PMID: 26168206 - 4
Anesthetic management of patient with hemophilia a undergoing emergency ventriculoperitoneal shunting: A case report and review of literature.
Khokhar RS, Hussain A, Khan MU, et al.
Saudi journal of anaesthesia 2016; (10(4)):474-476 doi:10.4103/1658-354X.179120.
PMID: 27833501 - 5
Hemophilia Management via Data Collection and Reporting: Initial Findings from the Comprehensive Care Sustainability Collaborative.
Tarantino MD, Pindolia VK
Journal of managed care & specialty pharmacy 2017; (23(1)):51-56 doi:10.18553/jmcp.2017.23.1.51.
PMID: 28025929 - 6
Physical therapy within US HTCs: A multicentre survey of utilization, practice patterns and pain management approaches.
Newman JR, Durben N, Baumann K, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2022; (28(2)):343-350 doi:10.1111/hae.14501.
PMID: 35152533 - 7
Hemophilic arthropathy: Current knowledge and future perspectives.
Gualtierotti R, Solimeno LP, Peyvandi F
Journal of thrombosis and haemostasis : JTH 2021; (19(9)):2112-2121 doi:10.1111/jth.15444.
PMID: 34197690 - 8
Defining the micro and macro roles of a hemophilia treatment center social worker in the United States from an interdisciplinary team perspective.
Bartlett DL, Schnur KM, Wilson AK, Moorman SS
Haemophilia : the official journal of the World Federation of Hemophilia 2022; (28(6)):e164-e171 doi:10.1111/hae.14612.
PMID: 35797008 - 9
Improving Hemophilia Care in Low- and Middle-Income Countries: Addressing Challenges and Enhancing Quality of Life.
Perolla A, Kalaja B
Cureus 2024; (16(6)):e62817 doi:10.7759/cureus.62817.
PMID: 39036274 - 10
Is the Detection of Factor IX Inhibitors in Hemophilia B Orphan than Factor VIII Inhibitors in Hemophilia A? A Concise, Systematic Review.
Mansouritorghabeh H, Mohades ST
Cardiovascular & hematological disorders drug targets 2020; (20(3)):185-190 doi:10.2174/1871529X20666200701104143.
PMID: 32611303 - 11
Improved outcomes and cost savings for patients with bleeding disorders: a quality improvement project.
Merrill SA, Webber SE, Merrill LJ, Shmookler AD
Research and practice in thrombosis and haemostasis 2024; (8(3)):102401 doi:10.1016/j.rpth.2024.102401.
PMID: 38706779 - 12
Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project.
Manco-Johnson MJ, Soucie JM, Gill JC,
Blood 2017; (129(17)):2368-2374 doi:10.1182/blood-2016-02-683169.
PMID: 28183693 - 13
Burden of illness: direct and indirect costs among persons with hemophilia A in the United States.
Zhou ZY, Koerper MA, Johnson KA, et al.
Journal of medical economics 2015; (18(6)):457-65 doi:10.3111/13696998.2015.1016228.
PMID: 25660324 - 14
Interfacility Collaboration for Hemophilia Care in Japan: A Retrospective Database Study Using a Japanese Healthcare Claims Database.
Kinai E, Yamaguchi M, Shirahata A
Health science reports 2026; (9(1)):e71643 doi:10.1002/hsr2.71643.
PMID: 41552376 - 15
Patient satisfaction with US Hemophilia Treatment Center Care, Teams and Services: The First National Survey.
Riske B, Shearer R, Baker JR
Haemophilia : the official journal of the World Federation of Hemophilia 2020; (26(6)):991-998 doi:10.1111/hae.14176.
PMID: 33094872 - 16
Practices and challenges for hemophilia management under resource constraints in Thailand.
Moonla C, Sosothikul D, Pongtanakul B, et al.
Orphanet journal of rare diseases 2023; (18(1)):110 doi:10.1186/s13023-023-02718-1.
PMID: 37161533 - 17
Invisible bleeds: Lived experiences and barriers to care for men with hemophilia.
Arya S, Siad FM, Wilton P, et al.
Journal of thrombosis and haemostasis : JTH 2022; (20(2)):296-306 doi:10.1111/jth.15570.
PMID: 34689399
This page is for informational purposes only and does not constitute medical advice. It describes Hemophilia Treatment Center care in general; ask your hematologist or HTC team about your personal treatment and emergency plan.